OptiBiotix Health PLC (OPTI)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

18.00p

Buy

19.00p

arrow-down-0.75p (-3.90%)

OptiBiotix Health PLC is a life sciences company. The company through its subsidiaries is engaged in the research and development of microbiome modulators.
Prices updated at 09 May 2025, 17:05 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Richard Colin Neil Davidson CBE
CEO
Mr. Stephen Patrick O'Hara
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
5
Head office
Innovation Centre, Innovation Way
York
United Kingdom
YO10 5DG
mobile
+44 1904435100
letter
info@optibiotix.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Richard Colin Neil Davidson CBE
Non-Executive Director, Chairman
-----
Mr. Michael Sean Christie
Non-Executive Director
-----
Dr. Sofia Kolyda
Executive Director, Research and Development
-----
Mr. Stephen Patrick O'Hara
Executive Director, Chief Executive Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
No data

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.